Table 1 Analysis of the association between the expression level of p-S6 and clinicopathological features of NSCLC (n = 350)
Clinicopathological features (n) | p-S6 | |||
|---|---|---|---|---|
N | High (%) | Low (%) | P-value | |
Age (years) | ||||
  ≤ 50 | 95 | 48 (50.5) | 47 (49.5) |  |
 >50 | 255 | 121 (47.5) | 134 (52.5) | 0.632 |
Gender | ||||
 Male | 266 | 114 (42.9) | 152 (57.1) |  |
 Female | 84 | 55 (65.5) | 29 (34.5) | 0.000a |
Clinical stage | ||||
 Stage I-II | 151 | 75 (49.7) | 76 (50.3) |  |
 Stage III | 199 | 93 (46.7) | 106 (53.3) | 0.519 |
LN status | ||||
 LNM | 210 | 117 (55.7) | 93 (44.3) |  |
 No LNM | 140 | 52 (37.1) | 88 (62.9) | 0.001a |
Histological type | ||||
 SCC | 154 | 47 (30.5) | 107 (69.5) |  |
 ADC | 196 | 122 (62.2) | 74 (37.8) | 0.000a |
Pathological grade | ||||
 Well/ Moderate | 152 | 77 (50.7) | 75 (49.3) |  |
 Poor | 198 | 92 (46.5) | 106 (53.5) | 0.452 |
Survival status | ||||
 Alive | 187 | 77 (41.2) | 110 (58.8) |  |
 Dead | 163 | 92 (56.4) | 71 (43.6) | 0.005a |